Pharmaceuticals 2010, 3(5), 1594-1613; doi:10.3390/ph3051594
Review

NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates

Division of Molecular Cell Immunology and Allergology, Nihon University Graduate School of Medical Science, Tokyo, Japan
* Author to whom correspondence should be addressed.
Received: 23 March 2010; in revised form: 26 April 2010 / Accepted: 14 May 2010 / Published: 19 May 2010
(This article belongs to the Special Issue Non-Steroidal Anti-Inflammatory Drugs)
PDF Full-text Download PDF Full-Text [739 KB, uploaded 19 May 2010 13:26 CEST]
Abstract: Aspirin (acetylsalicylic acid) is a well-known nonsteroidal anti-inflammatory drug (NSAID) that has long been used as an anti-pyretic and analgesic drug. Recently, much attention has been paid to the chemopreventive and apoptosis-inducing effects of NSAIDs in cancer cells. These effects have been thought to be primarily attributed to the inhibition of cyclooxygenase activity and prostaglandin synthesis. However, recent studies have demonstrated unequivocally that certain NSAIDs, including aspirin and its metabolite salicylic acid, exert their anti-inflammatory and chemopreventive effects independently of cyclooxygenase activity and prostaglandin synthesis inhibition. It is becoming increasingly evident that two potential common targets of NSAIDs are mitochondria and the Ca2+ signaling pathway. In this review, we provide an overview of the current knowledge regarding the roles of mitochondria and Ca2+ in the apoptosis-inducing effects as well as some side effects of aspirin, salicylates and other NSAIDs, and introducing the emerging role of L-type Ca2+ channels, a new Ca2+ entry pathway in non-excitable cells that is up-regulated in human cancer cells.
Keywords: aspirin; calcium; mitochondria; nonsteroidal anti-inflammatory drug (NSAID); reactive oxygen species

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Suzuki, Y.; Inoue, T.; Ra, C. NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates. Pharmaceuticals 2010, 3, 1594-1613.

AMA Style

Suzuki Y, Inoue T, Ra C. NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates. Pharmaceuticals. 2010; 3(5):1594-1613.

Chicago/Turabian Style

Suzuki, Yoshihiro; Inoue, Toshio; Ra, Chisei. 2010. "NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates." Pharmaceuticals 3, no. 5: 1594-1613.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert